Scimee(300425)2021-04-23 16:00Financial Performance - The company's revenue for Q1 2021 was ¥184,200,730.27, representing a 10.02% increase compared to ¥167,417,855.52 in the same period last year[10] - Net profit attributable to shareholders was ¥29,331,091.79, up 27.92% from ¥22,929,832.11 year-on-year[10] - The net profit after deducting non-recurring gains and losses was ¥25,317,397.42, a significant increase of 104.73% compared to ¥12,366,369.67 in the previous year[10] - Basic earnings per share rose to ¥0.0434, reflecting a 26.90% increase from ¥0.0342 in the same period last year[10] - The company achieved operating revenue of 184.20 million yuan, representing a year-on-year growth of 10.02%[21] - The net profit attributable to shareholders of the listed company was 29.33 million yuan, an increase of 27.92% year-on-year[21] - The significant increase in net profit was primarily driven by the increase in operating revenue[21] - Operating profit for the current period was ¥30,107,935.63, representing a 37% increase from ¥22,047,575.97 in the previous period[49] - Net profit for the current period was ¥28,299,121.22, which is a 17% increase compared to ¥24,131,668.67 from the previous period[50] - The total profit for the current period was ¥32,112,164.88, an increase of 16% from ¥27,788,957.89 in the previous period[50] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,457,531,586.23, a decrease of 1.60% from ¥3,513,601,386.32 at the end of the previous year[10] - The company's total liabilities were CNY 1,416,332,226.04, down from CNY 1,506,807,384.27, indicating a reduction of about 6%[42] - Non-current liabilities totaled CNY 272,681,128.23, compared to CNY 264,433,820.24 previously, reflecting an increase of approximately 1.4%[42] - The total current liabilities decreased to CNY 1,143,651,097.81 from CNY 1,242,373,564.03, indicating a reduction of about 7.9%[42] - The total equity attributable to shareholders reached CNY 1,889,584,507.25, up from CNY 1,859,437,178.54, showing an increase of approximately 1.3%[43] Cash Flow - The company reported a net cash flow from operating activities of -¥28,909,984.64, an improvement from -¥79,550,387.44 in the same period last year[10] - The cash flow from operating activities improved significantly, with a net cash flow of -28.91 million yuan, compared to -79.55 million yuan in the previous period[20] - The net cash flow from operating activities was -39,151,157.87, compared to -82,369,627.55 in the previous period, indicating an improvement[61] - Total cash and cash equivalents at the end of the period were 253,782,978.71, down from 322,770,378.94 at the beginning of the period[59] Research and Development - The company reported a 77.21% increase in R&D expenses, amounting to 7.97 million yuan, due to increased investment in research and development[20] - The company is currently developing 7 major R&D projects, including a rapid response wastewater treatment device and a new generation of magnetic separation technology[23] - The company has filed for 16 new patents, including practical new models and design patents, enhancing its core technology capabilities[24] Market and Competition - The company aims to enhance its market expansion and technology development in response to macroeconomic uncertainties and industry competition[26] - The company has identified significant risks related to macroeconomic changes and intensified industry competition, which could impact future performance[26][28] - The company is focusing on maintaining its core technology and innovation capabilities to mitigate risks associated with talent retention and market competition[29] Shareholder Information - The top shareholder, Beijing Zhongjian Qiming Enterprise Management Co., Ltd., holds 27.05% of the shares, totaling 182,809,171 shares[13] - The company has 20,892 common shareholders at the end of the reporting period[13] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[14] Operational Expenses - Sales expenses rose by 47.68% to 23.63 million yuan, attributed to more frequent sales activities following the effective control of the domestic COVID-19 pandemic[20] - The company’s payable employee compensation decreased by 79.14% to 16.88 million yuan, mainly due to the payment of year-end bonuses in the previous year[20] - The company’s tax payable decreased by 58.34% to 14.09 million yuan, primarily due to the payment of taxes accrued at the end of the previous year[20] Inventory and Receivables - Accounts receivable decreased from ¥905,192,287.18 to ¥843,499,601.66, reflecting a reduction of about 6.8%[40] - Inventory increased significantly from ¥288,661,509.99 to ¥369,510,527.24, representing a rise of approximately 28.0%[40]